Mormon Pharmaceuticals Private Limited
About Mormon Pharmaceuticals Private Limited
Data last updated:
Mormon Pharmaceuticals Private Limited is a private limited company based in Amravati, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 08 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2015PTC267324. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pravin Ambadas Theng and Mangesh Gunvantrao Pund.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Palash Line Opposite Of Vithall Wadi Apartment Gadge Nagar, Amravati, Maharashtra, India – 444603.
As per the financials filed for FY 2020, the company reported a revenue of ₹28.26 Lakh, a decline of 41% compared to the previous year. For the same year it recorded a net profit of ₹4,104 (net margin 0.1%) and EBITDA of ₹6,217 (EBITDA margin 0.2%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPalash Line Opposite Of Vithall Wadi Apartment Gadge Nagar, Amravati, Maharashtra, India – 444603
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity
The main business activity of Mormon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Mormon Pharmaceuticals Private Limited
FY 2020 filings availableMormon Pharmaceuticals Private Limited reported revenue of ₹28.26 Lakh (down 41% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over three years, including a 41% fall in the latest year. EBITDA fell 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2015-16 to FY 2018-19in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹28.26 Lakh | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹6,217 | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹4,104 | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2019-20 | FY 2015-16 to FY 2018-19in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.2% | |
| Net Profit Margin | 0.1% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2015-16 to FY 2018-19, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mormon Pharmaceuticals are in the company report.
: available in the company report
Board of Directors of Mormon Pharmaceuticals Private Limited
Mormon Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pravin Ambadas Theng | Director | 02 Jan 2016 | 10 Years 9 Months | Current |
| Mangesh Gunvantrao Pund | Director | 08 Aug 2015 | 11 Years 2 Months | Current |
| Niwrutti Hari Ingle | Director | 08 Aug 2015 | 11 Years 2 Months | Current |
Peer Comparison
Mormon Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kuiper Pharmaceuticals Private Limited | ₹28.33 Lakh (FY 2025) | •••• | •••• | 48.0% | •••• | Vikasnagar, Uttarakhand, India |
| Arobic Remedies and Pharmaceuticals Private Limited | ₹28.32 Lakh (FY 2022) | •••• | •••• | -29.0% | •••• | Nagpur, Maharashtra, India |
| Mormon Pharmaceuticals Private Limited this company | ₹28.26 Lakh (FY 2020) | •••• | •••• | -41.0% | •••• | Amravati, Maharashtra, India |
| Alphard Pharmaceuticals Private Limited | ₹28.23 Lakh (FY 2022) | •••• | •••• | •••• | Panvel, Maharashtra, India | |
| Eshar Pharmaceuticals Private Limited | ₹28.21 Lakh (FY 2023) | •••• | •••• | 4.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the companies nearest to Mormon Pharmaceuticals by revenue, above and below it, in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Mormon Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Mormon Pharmaceuticals.
: available in the company report
Recent Activity
Mormon Pharmaceuticals Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Rahul Sahebrao Pote ceased to be Director on 02 Mar 2017.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Mormon Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Mormon Pharmaceuticals is an active private limited company based in Amravati, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 08 August 2015 (11+ years old) and is registered under CIN U85100MH2015PTC267324.
Mormon Pharmaceuticals has 3 current directors:
- Pravin Ambadas Theng - Director
- Mangesh Gunvantrao Pund - Director
- Niwrutti Hari Ingle - Director
The latest financial statements of Mormon Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2016 are in the company report.
No. Mormon Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Mormon Pharmaceuticals is U85100MH2015PTC267324. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mormon Pharmaceuticals was incorporated on 08 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Mormon Pharmaceuticals by revenue are Kuiper Pharmaceuticals Private Limited, Arobic Remedies and Pharmaceuticals Private Limited, Alphard Pharmaceuticals Private Limited, Eshar Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Rahul Sahebrao Pote ceased to be Director on 02 Mar 2017. Pravin Ambadas Theng was appointed as Director on 02 Jan 2016. Mangesh Gunvantrao Pund was appointed as Director on 08 Aug 2015. Mormon Pharmaceuticals has 4 board changes on record in total.
The registered office of Mormon Pharmaceuticals is at Palash Line Opposite Of Vithall Wadi Apartment Gadge Nagar, Amravati, Maharashtra, India – 444603.
Mormon Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Mormon Pharmaceuticals is compliant as of 10 July 2026. The company is actively filing with the Registrar of Companies.